Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

• Status: Completed
• Trial end date: 2004-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical research study is to assess the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
• Collaborator: Otsuka America Pharmaceutical
• Treatments: Aripiprazole

Criteria

Inclusion Criteria:

• Primary diagnosis of idiopathic Parkinson's disease.

• Psychosis related to Parkinson's disease.

Exclusion Criteria:

• Psychosis present prior to diagnosis of Parkinson's disease.